Law360, New York (September 7, 2016, 7:29 PM EDT) — A California federal judge refused Wednesday to overturn a $12.3 million jury verdict against a UnitedHealth unit found to have infringed a patent for technology that measures doctors’ efficiency — but also refused the victorious plaintiff, Cave Consulting Group LLC, an injunction or an answer on ongoing royalties.
In March 2015, a jury awarded Cave more than $12.3 million, saying UnitedHealth Group Inc. unit OptumInsight Inc’s Impact Intelligence product infringed two claims of Cave’s patent for products that try to calculate doctor efficiency and also categorize patient health risk. The jury also rejected counterclaims that Cave software infringed an Optum patent.
